Medical AI

Abu Dhabi and MIT Solve are funding frontline AI to predict outbreaks. But can these innovations survive the treacherous path to public adoption?

A new partnership between Beacon Biosignals and Project Sleep aims to dismantle the 11-year diagnostic delay for hypersomnia using at-home AI neurotechnology.

Moving beyond traditional DNA sequencing, BostonGene’s biologically grounded AI helps oncologists and biopharma uncover hidden cancer resistance mechanisms.

As sub-Saharan Africa battles a severe cervical cancer crisis, offline edge AI is stepping in where traditional labs fall short to bridge the diagnostic divide.

A new partnership between Neumarker and Cortica aims to end the trial-and-error approach in autism care by using AI to analyze complex brain wave data.

SpotitEarly's Bio-AI platform combines canine scent detection with machine learning to spot early-stage cancer. Will regulatory hurdles stall its 2027 launch?

As AI healthcare projections surpass $1 trillion, micro-cap firms face the harsh financial realities of scaling cross-border virtual care in the U.S.

CellTivity Scientific's Van Gogh system hits a major milestone, proving that real-time metabolic imaging is shifting from a niche tool to a surgical standard.

A new partnership between WeInfuse and Clarion integrates AI into specialty clinics, tackling burnout and the logistical chaos of infusion care.

Brainomix and the PFF are turning complex AI imaging into actionable patient insights, signaling a major shift in the $15.7B antifibrotic market.

By putting pocket ultrasounds in medical students' hands, Butterfly Network isn't just selling hardware—it's building a lifetime subscription ecosystem.

A landmark 6,000-person trial by Holobiome and Radicle Science is utilizing AI and decentralized testing to see if food can solve anxiety.

Tech elites are pouring billions into reversing aging, but top scientists at an exclusive retreat just delivered a surprising reality check on human lifespan.

Oku Digital Health is bringing AI-powered retinal screening to primary care, turning the eye into a window for cardiovascular and systemic health.

As liver cancer deaths near 31,000 annually, a new House resolution and AI-driven blood tests aim to fix a broken screening system for high-risk patients.

AIRS Medical's FDA-cleared SwiftSight transforms MRI body composition into a sub-five-minute, radiation-free scan, unlocking new revenue for imaging centers.

A new integration between Demandforce and Practice Fusion highlights how independent medical practices are turning to AI to combat burnout and win local search.

As 20/20 BioLabs brings its needle-free, AI-powered cancer tests to the Maxim Growth Summit, the startup faces intense scrutiny over its financial runway.

NORD's latest $145,000 seed funding proves that in the overlooked world of rare diseases, modest philanthropic grants are the ultimate catalyst for innovation.

Verily Health is pivoting to federal infrastructure, securing a central role in ARPA-H's $144.9 million moonshot to cut ICU stays by 25 percent using AI.